CAMP4 Therapeutics Corporation Common Stock (CAMP) is a publicly traded Healthcare sector company. As of May 21, 2026, CAMP trades at $4.50 with a market cap of $236.78M and a P/E ratio of -1.90. CAMP moved +8.80% today. Year to date, CAMP is -24.87%; over the trailing twelve months it is +101.79%. Its 52-week range spans $1.31 to $12.30. Analyst consensus is strong buy with an average price target of $8.60. Rallies surfaces CAMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CAMP combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.50 |
| Market Cap | $236.78M |
| P/E Ratio | -1.90 |
| EPS | $-2.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.30 |
| 52-Week Low | $1.31 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.93M |
| Net Income | $-86.30M |
| Gross Margin | 0.00% |
6 analysts cover CAMP: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.60.